These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31017567)

  • 1. Epistatic interactions can moderate the antigenic effect of substitutions in haemagglutinin of influenza H3N2 virus.
    Koel BF; Burke DF; van der Vliet S; Bestebroer TM; Rimmelzwaan GF; Osterhaus ADME; Smith DJ; Fouchier RAM
    J Gen Virol; 2019 May; 100(5):773-777. PubMed ID: 31017567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.
    Koel BF; Burke DF; Bestebroer TM; van der Vliet S; Zondag GC; Vervaet G; Skepner E; Lewis NS; Spronken MI; Russell CA; Eropkin MY; Hurt AC; Barr IG; de Jong JC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA; Smith DJ
    Science; 2013 Nov; 342(6161):976-9. PubMed ID: 24264991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.
    Abente EJ; Santos J; Lewis NS; Gauger PC; Stratton J; Skepner E; Anderson TK; Rajao DS; Perez DR; Vincent AL
    J Virol; 2016 Sep; 90(18):8266-80. PubMed ID: 27384658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of influenza A(H3N2) viruses during the 2016/2017 season in Bulgaria.
    Korsun N; Angelova S; Trifonova I; Tzotcheva I; Mileva S; Voleva S; Georgieva I; Perenovska P
    J Med Microbiol; 2018 Feb; 67(2):228-239. PubMed ID: 29297852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and antigenic characterization of the H3 hemagglutinin of H3N2 influenza A virus strains collected in the Czech Republic during the 2014/2015 epidemic season.
    Nagy A; Jiřincová H; Kynčl J; Havlíčková M
    Epidemiol Mikrobiol Imunol; 2016; 65(2):92-101. PubMed ID: 27467326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.
    de Jong JC; Smith DJ; Lapedes AS; Donatelli I; Campitelli L; Barigazzi G; Van Reeth K; Jones TC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2007 Apr; 81(8):4315-22. PubMed ID: 17287258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin.
    García-Barreno B; Delgado T; Benito S; Casas I; Pozo F; Cuevas MT; Mas V; Trento A; Rodriguez-Frandsen A; Falcón A; Ortín J; Nieto A; Melero JA
    J Gen Virol; 2014 May; 95(Pt 5):1033-1042. PubMed ID: 24531414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
    Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
    J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation.
    Du X; Dong L; Lan Y; Peng Y; Wu A; Zhang Y; Huang W; Wang D; Wang M; Guo Y; Shu Y; Jiang T
    Nat Commun; 2012 Feb; 3():709. PubMed ID: 22426230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin.
    Kobayashi Y; Suzuki Y
    J Virol; 2012 Apr; 86(7):3446-51. PubMed ID: 22258255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
    J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic variation of the human influenza A (H3N2) virus during the 2014-2015 winter season.
    Hua S; Li X; Liu M; Cheng Y; Peng Y; Huang W; Tan M; Wei H; Guo J; Wang D; Wu A; Shu Y; Jiang T
    Sci China Life Sci; 2015 Sep; 58(9):882-8. PubMed ID: 26219513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018-2019 winter season.
    Korsun N; Daniels R; Angelova S; Ermetal B; Grigorova I; Voleva S; Trifonova I; Kurchatova A; McCauley J
    J Med Microbiol; 2020 Jul; 69(7):986-998. PubMed ID: 32459617
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticipating time-dependent antigenic variants of influenza A (H3N2) viruses.
    Adabor ES
    Infect Genet Evol; 2019 Jan; 67():67-72. PubMed ID: 30391719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology. Influenza escapes immunity along neutral networks.
    van Nimwegen E
    Science; 2006 Dec; 314(5807):1884-6. PubMed ID: 17185589
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany.
    Wedde M; Biere B; Wolff T; Schweiger B
    Int J Med Microbiol; 2015 Oct; 305(7):762-75. PubMed ID: 26416089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using sequence data to infer the antigenicity of influenza virus.
    Sun H; Yang J; Zhang T; Long LP; Jia K; Yang G; Webby RJ; Wan XF
    mBio; 2013 Jul; 4(4):. PubMed ID: 23820391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictability of antigenic evolution for H3N2 human influenza A virus.
    Suzuki Y
    Genes Genet Syst; 2013; 88(4):225-32. PubMed ID: 24463525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.